Michelle Anne Farrar (Michelle A Farrar, Michelle Farrar)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 32

Top Venues

Journal of neurology, neurosurgery, and psychiatry

Pharmaceutics

Muscle & nerve

Developmental medicine and child neurology

University of New South Wales

University of New South Wales (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of New South Wales

Australia

Senior Lecturer, Paediatric Neurology :: School of Women's and Children's Health, UNSW Medicine

Sydney Children's Hospital

Australia

Paediatric Neurologist :: Paediatric Neurology

Education History

University of New South Wales

Australia

PHD

Publications

Christina Q Nguyen, Didu S T Kariyawasam, Tsz Shun Jason Ngai, James Nguyen, Kristine Concepcion, Sarah E Grattan, Emma Elizabeth Palmer, Kate Hetherington, Claire E Wakefield, Russell C Dale, Susan R Woolfenden, Shekeeb S Mohammad, Michelle Anne Farrar
'High hopes for treatment': Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseases. Health expectations : an international journal of public participation in health care and health policy 27 (3) (2024)
Christina Q Nguyen, Didu S T Kariyawasam, Tsz Shun Jason Ngai, James Nguyen, Kristine Concepcion, Sarah E Grattan, Emma Elizabeth Palmer, Kate Hetherington, Claire E Wakefield, Russell C Dale, Susan R Woolfenden, Shekeeb S Mohammad, Michelle Anne Farrar
'High hopes for treatment': Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseases. Health expectations : an international journal of public participation in health care and health policy 27 (3) (2024)
Natassja Billich, Paula Bray, Helen Truby, Maureen Evans, Monique M Ryan, Kate Carroll, Katy de Valle, Daniella Villano, Andrew J Kornberg, Bianca Sowerby, Michelle Anne Farrar, Manoj P Menezes, Sandra Holland, Rachel Lindeback, Anita Cairns, Zoe E Davidson
Exploring caregivers' attitudes and beliefs about nutrition and weight management for young people with Duchenne muscular dystrophy. Muscle & nerve 69 (4) (2024)
Natassja Billich, Paula Bray, Helen Truby, Maureen Evans, Monique M Ryan, Kate Carroll, Katy de Valle, Daniella Villano, Andrew J Kornberg, Bianca Sowerby, Michelle Anne Farrar, Manoj P Menezes, Sandra Holland, Rachel Lindeback, Anita Cairns, Zoe E Davidson
Exploring caregivers' attitudes and beliefs about nutrition and weight management for young people with Duchenne muscular dystrophy. Muscle & nerve 69 (4) (2024)
Natassja Billich, Paula Bray, Helen Truby, Maureen Evans, Monique M Ryan, Kate Carroll, Katy de Valle, Daniella Villano, Andrew J Kornberg, Bianca Sowerby, Michelle Anne Farrar, Manoj P Menezes, Sandra Holland, Rachel Lindeback, Anita Cairns, Zoe E Davidson
Exploring caregivers' attitudes and beliefs about nutrition and weight management for young people with Duchenne muscular dystrophy. Muscle & nerve (2024)
Arlene M D'Silva, Didu Kariyawasam, Pooja Venkat, Chelsea Mayoh, Michelle Anne Farrar
Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study. Pharmaceutics 15 (1) (2023)
Victor D Armengol, Basil T Darras, Ahmad Abdulaziz Abulaban, Ali Alshehri, Nina Barisic, Tawfeg Ben-Omran, Guenther Bernert, Claudia Castiglioni, Yin-Hsiu Chien, Michelle Anne Farrar, Gwendoline Q Kandawasvika, Satish V Khadilkar, Jean K Mah, Chiara Marini-Bettolo, Damjan Osredkar, Gerald Pfeffer, Flavia B Piazzon, Inmaculada Pitarch Castellano, Susana Quijano-Roy, Kayoko Saito, Jin-Hong Shin, Juan Francisco Vázquez Costa, Maggie C Walter, Jithangi Wanigasinghe, Hui Xiong, Robert C Griggs, Bhaskar Roy
Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability. Neurology. Clinical practice 14 (1) (2023)
Arlene M D'Silva, Didu Kariyawasam, Pooja Venkat, Chelsea Mayoh, Michelle Anne Farrar
Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study. Pharmaceutics 15 (1) (2023)
Victor D Armengol, Basil T Darras, Ahmad Abdulaziz Abulaban, Ali Alshehri, Nina Barisic, Tawfeg Ben-Omran, Guenther Bernert, Claudia Castiglioni, Yin-Hsiu Chien, Michelle Anne Farrar, Gwendoline Q Kandawasvika, Satish V Khadilkar, Jean K Mah, Chiara Marini-Bettolo, Damjan Osredkar, Gerald Pfeffer, Flavia B Piazzon, Inmaculada Pitarch Castellano, Susana Quijano-Roy, Kayoko Saito, Jin-Hong Shin, Juan Francisco Vázquez Costa, Maggie C Walter, Jithangi Wanigasinghe, Hui Xiong, Robert C Griggs, Bhaskar Roy
Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability. Neurology. Clinical practice 14 (1) (2023)
Joanne E Davidson, Jacqueline S Russell, Noelia Nunez Martinez, David R Mowat, Kristi J Jones, Edwin P Kirk, Didu Kariyawasam, Michelle Anne Farrar, Arlene D'Silva
The Carrier Frequency of Two SMN1 Genes in Parents of Symptomatic Children with SMA and the Significance of SMN1 Exon 8 in Carriers. Genes 14 (7) (2023)
Arlene M D'Silva, Didu Kariyawasam, Pooja Venkat, Chelsea Mayoh, Michelle Anne Farrar
Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study. Pharmaceutics 15 (1) (2023)
Matthew C Kiernan, Michelle Anne Farrar
Emerging role for sphingolipids in the genetics of amyotrophic lateral sclerosis. Journal of neurology, neurosurgery, and psychiatry (2023)
Arlene M D'Silva, Didu Kariyawasam, Pooja Venkat, Chelsea Mayoh, Michelle Anne Farrar
Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study. Pharmaceutics 15 (1) (2023)
Victor D Armengol, Basil T Darras, Ahmad Abdulaziz Abulaban, Ali Alshehri, Nina Barisic, Tawfeg Ben-Omran, Guenther Bernert, Claudia Castiglioni, Yin-Hsiu Chien, Michelle Anne Farrar, Gwendoline Q Kandawasvika, Satish V Khadilkar, Jean K Mah, Chiara Marini-Bettolo, Damjan Osredkar, Gerald Pfeffer, Flavia B Piazzon, Inmaculada Pitarch Castellano, Susana Quijano-Roy, Kayoko Saito, Jin-Hong Shin, Juan Francisco Vázquez Costa, Maggie C Walter, Jithangi Wanigasinghe, Hui Xiong, Robert C Griggs, Bhaskar Roy
Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability. Neurology. Clinical practice 14 (1) (2023)
Christina Q Nguyen, Didu S T Kariyawasam, Kristine Concepcion, Sarah E Grattan, Kate Hetherington, Claire E Wakefield, Susan R Woolfenden, Russell C Dale, Emma Elizabeth Palmer, Michelle Anne Farrar
'Advocacy groups are the connectors': Experiences and contributions of rare disease patient organization leaders in advanced neurotherapeutics. Health expectations : an international journal of public participation in health care and health policy 25 (6) (2022)
Michelle Anne Farrar, Matthew C Kiernan
Spinal muscular atrophy - the dawning of a new era. Nature reviews. Neurology 16 (11) (2022)
Susan R Woolfenden, Michelle Anne Farrar, Valsamma Eapen, Anne Masi, Claire E Wakefield, Nadia Badawi, Iona Novak, Natasha Nassar, Raghu Lingam, Russell C Dale
Delivering paediatric precision medicine: Genomic and environmental considerations along the causal pathway of childhood neurodevelopmental disorders. Developmental medicine and child neurology 64 (9) (2022)
Kevin A Strauss, Michelle Anne Farrar, Francesco Muntoni, Kayoko Saito, Jerry R Mendell, Laurent Servais, Hugh J Mcmillan, Richard S Finkel, Kathryn J Swoboda, Jennifer M Kwon, Craig M Zaidman, Claudia A Chiriboga, Susan T Iannaccone, Jena M Krueger, Julie A Parsons, Perry B Shieh, Sarah Kavanagh, Sitra Tauscher-Wisniewski, Bryan E McGill, Thomas A Macek
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial. Nature medicine 28 (7) (2022)
Kevin A Strauss, Michelle Anne Farrar, Francesco Muntoni, Kayoko Saito, Jerry R Mendell, Laurent Servais, Hugh J Mcmillan, Richard S Finkel, Kathryn J Swoboda, Jennifer M Kwon, Craig M Zaidman, Claudia A Chiriboga, Susan T Iannaccone, Jena M Krueger, Julie A Parsons, Perry B Shieh, Sarah Kavanagh, Melissa Wigderson, Sitra Tauscher-Wisniewski, Bryan E McGill, Thomas A Macek
Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial. Nature medicine 28 (7) (2022)
Drew MacCannell, Zdenek Berger, Janbernd Kirschner, Eugenio Mercuri, Michelle Anne Farrar, Susan T Iannaccone, Nancy L Kuntz, Richard S Finkel, Marta Valente, Francesco Muntoni
Restoration of Nusinersen Levels Following Treatment Interruption in People With Spinal Muscular Atrophy: Simulations Based on a Population Pharmacokinetic Model. CNS drugs 36 (2) (2022)
Christina Q Nguyen, Kristine Concepcion, Emma Elizabeth Palmer, Jackie Leach Scully, Nicole Millis, Michelle Anne Farrar
The involvement of rare disease patient organisations in therapeutic innovation across rare paediatric neurological conditions: a narrative review. Orphanet journal of rare diseases 17 (1) (2022)
Kate A Carey, Michelle Anne Farrar, Nadine A Kasparian, Deborah J Street, Richard De Abreu Lourenco
Family, healthcare professional, and societal preferences for the treatment of infantile spinal muscular atrophy: A discrete choice experiment. Developmental medicine and child neurology 64 (6) (2021)
Arlene M D'Silva, Didu S T Kariyawasam, Stephanie Best, Veronica Wiley, Michelle Anne Farrar, null null
Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme. Developmental medicine and child neurology (2021)
Sophy Ting-Fang Shih, Michelle Anne Farrar, Veronica Wiley, Georgina Chambers
Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis. Journal of neurology, neurosurgery, and psychiatry 92 (12) (2021)
Hamish W Y Wan, Kate A Carey, Arlene D'Silva, Steve Vucic, Matthew C Kiernan, Nadine A Kasparian, Michelle Anne Farrar
Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review. Orphanet journal of rare diseases 15 (1) (2020)
Arlene D'Silva, Michelle Anne Farrar
Personalized medicine for children with spinal muscular atrophy: Toward the holy grail. Muscle & nerve 62 (4) (2020)
Didu S T Kariyawasam, Arlene D'Silva, James Howells, Karen Herbert, Peter Geelan-Small, Cindy Shin-Yi Lin, Michelle Anne Farrar
Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen. Journal of neurology, neurosurgery, and psychiatry (2020)
Didu Kariyawasam, Ian E Alexander, Manju Kurian, Michelle Anne Farrar
Great expectations: virus-mediated gene therapy in neurological disorders. Journal of neurology, neurosurgery, and psychiatry 91 (8) (2020)
Michelle Anne Farrar, Matthew C Kiernan
Treating adults with spinal muscular atrophy with nusinersen. Journal of neurology, neurosurgery, and psychiatry 91 (11) (2020)
Hamish W Y Wan, Kate A Carey, Arlene D'Silva, Nadine A Kasparian, Michelle Anne Farrar
"Getting ready for the adult world": how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being. Orphanet journal of rare diseases 14 (1) (2019)
Hooi Ling Teoh, Kate A Carey, Hugo Sampaio, David Mowat, Tony Roscioli, Michelle Anne Farrar
Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy. Neural plasticity 2017 (2017)
Megan H Brewer, Rabia Chaudhry, Jessica Qi, Aditi Kidambi, Alexander P Drew, Manoj P Menezes, Monique M Ryan, Michelle Anne Farrar, David Mowat, Gopinath M Subramanian, Helen K Young, Stephan Zuchner, Stephen W Reddel, Garth A Nicholson, Marina L Kennerson
Whole Genome Sequencing Identifies a 78 kb Insertion from Chromosome 8 as the Cause of Charcot-Marie-Tooth Neuropathy CMTX3. PLoS genetics 12 (7) (2016)

Michelle Anne Farrar.css-eqlu8i{font-size:small;padding-left:4px;} (Michelle A Farrar, Michelle Farrar)

Publication Activity (10 Years)

Top Topics

Top Venues

Michelle Anne Farrar (Michelle A Farrar, Michelle Farrar)